PAVmed Inc (NASDAQ:PAVM) subsidiary Lucid Diagnostics Inc (NASDAQ: LUCD) Chairman and CEO Dr. Lishan Aklog talks to Proactive about the updated American College of Gastroenterology clinical guideline, which he says specifically mentions Lucid's products.
Dr. Aklog says the new guidelines support esophageal precancer screening with EsoGuard on samples collected with EsoCheck, and describes how thiss may impact PAVmed and Lucid going forward.